Jakarta - Delayed Quote IDR
PT Siloam International Hospitals Tbk (SILO.JK)
2,600.00
+220.00
+(9.24%)
At close: April 30 at 4:13:44 PM GMT+7
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
12,207,563,000
12,207,563,000
11,190,511,000
9,518,012,000
9,381,891,000
Cost of Revenue
7,345,531,000
7,345,531,000
6,735,289,000
5,984,623,000
5,764,949,000
Gross Profit
4,862,032,000
4,862,032,000
4,455,222,000
3,533,389,000
3,616,942,000
Operating Expense
3,032,244,000
3,032,244,000
2,670,472,000
2,419,394,000
2,481,790,000
Operating Income
1,829,788,000
1,829,788,000
1,784,750,000
1,113,995,000
1,135,152,000
Net Non Operating Interest Income Expense
-66,281,000
-66,281,000
-61,785,000
-37,947,000
-45,838,000
Pretax Income
1,360,362,000
1,360,362,000
1,666,409,000
984,307,000
972,865,000
Tax Provision
410,248,000
410,248,000
419,365,000
273,926,000
272,681,000
Net Income Common Stockholders
902,152,000
902,152,000
1,211,283,000
696,495,000
674,117,000
Diluted NI Available to Com Stockholders
902,152,000
902,152,000
1,211,283,000
696,495,000
674,117,000
Basic EPS
69.49
--
93.27
70.74
52.12
Diluted EPS
69.19
--
92.92
70.59
52.11
Basic Average Shares
12,982,297.10
--
12,986,802.10
9,845,594.89
12,933,941
Diluted Average Shares
13,039,071.70
--
13,035,494.64
9,866,982.89
12,937,175.74
Total Operating Income as Reported
1,426,643,000
1,426,643,000
1,728,285,000
1,022,332,000
1,018,703,000
Rent Expense Supplemental
123,653,000
123,653,000
78,821,000
14,111,000
46,407,000
Total Expenses
10,377,775,000
10,377,775,000
9,405,761,000
8,404,017,000
8,246,739,000
Net Income from Continuing & Discontinued Operation
902,152,000
902,152,000
1,211,283,000
696,495,000
674,117,000
Normalized Income
1,098,140,486.89
1,098,140,486.89
1,216,446,560.45
696,495,000
722,553,713.42
Interest Income
29,775,000
29,775,000
21,975,000
29,917,000
19,147,000
Interest Expense
57,477,000
57,477,000
51,860,000
38,332,000
37,916,000
Net Interest Income
-66,281,000
-66,281,000
-61,785,000
-37,947,000
-45,838,000
EBIT
1,417,839,000
1,417,839,000
1,718,269,000
1,022,639,000
1,010,781,000
EBITDA
2,279,652,000
2,279,652,000
2,528,586,000
1,821,145,000
1,759,077,000
Reconciled Cost of Revenue
7,345,531,000
7,345,531,000
6,735,289,000
5,984,623,000
5,764,949,000
Reconciled Depreciation
861,813,000
861,813,000
810,317,000
798,506,000
748,296,000
Net Income from Continuing Operation Net Minority Interest
902,152,000
902,152,000
1,211,283,000
696,495,000
674,117,000
Total Unusual Items Excluding Goodwill
-280,614,000
-280,614,000
-6,900,000
--
-67,300,000
Total Unusual Items
-280,614,000
-280,614,000
-6,900,000
--
-67,300,000
Normalized EBITDA
2,560,266,000
2,560,266,000
2,535,486,000
1,821,145,000
1,826,377,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-84,625,513.11
-84,625,513.11
-1,736,439.55
--
-18,863,286.58
12/31/2021 - 9/12/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade